VivoSeq
Other

Intraperitoneal

0

Pipeline Programs

5

Active Trials

0

Companies Involved

Intraperitoneal is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

88/100

Attrition Rate

8/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

38

clinical trials

Completed21 · 55%
Unknown status9 · 24%
Recruiting4 · 11%
Terminated2 · 5%
Active, not recruiting1 · 3%
Withdrawn1 · 3%

Trial Activity

38 trials

Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)